<TABLE> <S> <C>


<ARTICLE>                  5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM SCANTEK
MEDICAL, INC. FINANCIAL STATEMENTS AT SEPTEMBER 30, 2000 AND THE THREE MONTHS
THEN ENDED AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER>               1

<S>                                                          <C>
<PERIOD-TYPE>                                                 12-MOS
<FISCAL-YEAR-END>                                                            JUN-30-2000
<PERIOD-END>                                                                 SEP-30-2000
<CASH>                                                                             1,409
<SECURITIES>                                                                      14,252
<RECEIVABLES>                                                                     24,000
<ALLOWANCES>                                                                           0
<INVENTORY>                                                                      661,672
<CURRENT-ASSETS>                                                                 701,578
<PP&E>                                                                         2,102,059
<DEPRECIATION>                                                                   628,909
<TOTAL-ASSETS>                                                                 2,259,000
<CURRENT-LIABILITIES>                                                          5,671,551
<BONDS>                                                                                0
<COMMON>                                                                          18,890
                                                                  0
                                                                            0
<OTHER-SE>                                                                    (5,602,556)
<TOTAL-LIABILITY-AND-EQUITY>                                                   2,259,000
<SALES>                                                                                0
<TOTAL-REVENUES>                                                                       0
<CGS>                                                                            149,860
<TOTAL-COSTS>                                                                    462,811
<OTHER-EXPENSES>                                                                       0
<LOSS-PROVISION>                                                                       0
<INTEREST-EXPENSE>                                                               152,894
<INCOME-PRETAX>                                                                 (615,691)
<INCOME-TAX>                                                                           0
<INCOME-CONTINUING>                                                             (615,691)
<DISCONTINUED>                                                                         0
<EXTRAORDINARY>                                                                        0
<CHANGES>                                                                              0
<NET-INCOME>                                                                    (615,691)
<EPS-BASIC>                                                                         (.03)
<EPS-DILUTED>                                                                       (.03)



</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission